| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 03/09/2006 | US20060051777 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/09/2006 | US20060051776 Gene manipulation method using homologous recombination |
| 03/09/2006 | US20060051774 Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of prostate cancer |
| 03/09/2006 | US20060051773 Method for the mutagenesis of nucleotide sequences in plants, algae or fungi |
| 03/09/2006 | US20060051766 Canine cyp1a2 genetic polymorphism |
| 03/09/2006 | US20060051759 Compositions and methods relating to breast specific genes and proteins |
| 03/09/2006 | US20060051757 Diagnostic and therapeutic use of ensadin-0477 gene and protein for neurodegenerative diseases |
| 03/09/2006 | US20060051754 Transporter selectively transporting sulfate conjugate and its gene |
| 03/09/2006 | US20060051750 Method for fixing biomolecule on carrier |
| 03/09/2006 | US20060051748 Multi-site mutagenesis |
| 03/09/2006 | US20060051747 infecting human embryonic retinoblast with an influenza virus, then culturing and allowing for expression of said influenza virus and influenza viral protein, and harvesting influenza virus and/or influenza viral protein uses as vaccines |
| 03/09/2006 | US20060051743 Screening nucleic acid comprising sequence that encodes reverse transciptase domain of DNA polymerase for adefovir-resistant mutations; use in vaccine development |
| 03/09/2006 | US20060051740 Method for the amplification and detection of hbv dna using a transcription based amplification |
| 03/09/2006 | US20060051739 Methods and composition for visualizing and interfering with chromosomal tethering of extrachromosomal molecules |
| 03/09/2006 | US20060051426 Nanoparticles containing polymeric nucleic acid homologs pharmaceutical composition and articles of manufacture containing same and methods of use thereof |
| 03/09/2006 | US20060051405 Compositions for the delivery of therapeutic agents and uses thereof |
| 03/09/2006 | US20060051371 immunogenic non-haemolytic strain of Actinobacillus pleuropneumoniae which is modified in segment of apxIA gene and optionally in segment of apxIIA gene that encodes transmembrane domain of Apx haemolytic and cytolytic exotoxins; comprises also strains and attenuated live vaccine porcine pleuorpneumonia |
| 03/09/2006 | US20060051370 Microorganisms for therapy |
| 03/09/2006 | US20060051369 ADAR1 antiviral pathway |
| 03/09/2006 | US20060051368 Herpes simplex virus mutations |
| 03/09/2006 | US20060051367 Antigenic polypeptide sequences of factor VIII, and fragments and/or epitopes of these sequences |
| 03/09/2006 | US20060051365 Immunogenic composition |
| 03/09/2006 | US20060051363 Protein inducing cell death of helicobacter pylori |
| 03/09/2006 | US20060051358 Immune response assessment method |
| 03/09/2006 | US20060051356 Clostridial toxin derivatives able to modify peripheral sensory afferent functions |
| 03/09/2006 | US20060051350 Methods and means to suppress symptoms of an allergic disease by inhibiting the glucocorticoid-induced tumor necrosis factor receptor (GITR or TNFRSF18) |
| 03/09/2006 | US20060051346 Humanized anti-CD4 antibody with immunosuppressive properties |
| 03/09/2006 | US20060051335 fusing cells: nucleic acid vector comprises a nucleotide sequence encoding a syncytium-inducing polypeptide that is expressible on a eukaryotic cell surface and comprises a sequence of a gibbon ape leukemia virus |
| 03/09/2006 | US20060051333 AAV virions with decreased immunoreactivity and uses therefor |
| 03/09/2006 | US20060051332 Generation of histocompatible tissues using nuclear transplantation |
| 03/09/2006 | US20060051331 Optimization of transgene expression in mammalian cells |
| 03/09/2006 | US20060051329 Microfluidic device for the encapsulation of cells with low and high cell densities |
| 03/09/2006 | US20060051326 Treating brain damage by genetically modifying nestin-positive cells with c-myc oncogene; differentiation; stroke, ischemia, cerebral palsy, Alzheimer's, neurodegenerative diseases, dementia, Parkinson's, Huntington's disease |
| 03/09/2006 | US20060051325 Isolation and use of solid tumor stem cells |
| 03/09/2006 | US20060051295 Estrogen receptor interaction with a transcription factor |
| 03/09/2006 | DE10256669B4 Gemisch mindestens zweier Fusionsproteine sowie ihre Herstellung und Verwendung Mixture of at least two fusion proteins and their preparation and use |
| 03/09/2006 | DE102004045332B3 Process and assembly to elute single and twin-strand nucleic acids from a sample substrate substance in the presence of a bivalent metal ion |
| 03/09/2006 | DE102004043782A1 Polypeptide und Verfahren zur spezifischen Bindung von Prionen Polypeptides and methods for the specific binding of prions |
| 03/09/2006 | DE10108412B4 Pigmentepithelzelle des Auges, ihre Herstellung und Verwendung in der Therapie einer Augen- oder Nervenerkrankung Pigment epithelial cell of the eye, their preparation and use in the therapy of a nervous disease or eye |
| 03/09/2006 | DE10046932B4 Expressionssystem zur Überexpression von Kupfer-abhängigen sekretierten Proteinen in eukaryontischen Zellen Expression system for overexpression of copper-dependent secreted proteins in eukaryotic cells |
| 03/09/2006 | DE10019195B4 Reversible Immortalisierung Reversible immortalization |
| 03/09/2006 | CA2614580A1 Two-dimensional strandness- and length-dependent separation of nucleic acid fragments |
| 03/09/2006 | CA2594672A1 Methods and compositions to inhibit p2x7 receptor expression |
| 03/09/2006 | CA2591532A1 Nucleic acid sequences encoding proteins capable of associating into a virus-like particle |
| 03/09/2006 | CA2589591A1 Malate synthase regulatory sequences for heterologous gene expression in pichia |
| 03/09/2006 | CA2579094A1 Use of polypeptides obtained through systematic mutations of single amino acids of human and non-human box-a of hmgb1 to prevent and/or antagonize pathologies induced by hmgb1 |
| 03/09/2006 | CA2578904A1 Chemokine binding activity of viral tnf receptors and related proteins |
| 03/09/2006 | CA2578798A1 Salt responsive genes useful for generating salt resistant transgenic plants |
| 03/09/2006 | CA2578794A1 Salt resistant transgenic plants |
| 03/09/2006 | CA2578616A1 Conjugate of peo with double-stranded nucleic acid |
| 03/09/2006 | CA2578564A1 Method of error reduction in nucleic acid populations |
| 03/09/2006 | CA2578546A1 Method for determining protein solubility |
| 03/09/2006 | CA2578403A1 Recombinant mva viruses expressing clade a/g, clade b, and clade c modified hiv, gag and pol genes |
| 03/09/2006 | CA2577470A1 Fiber-modified adenoviral vectors for enhanced transduction of tumor cells |
| 03/09/2006 | CA2576813A1 Herbicide-resistant sunflower plants, polynucleotides encoding herbicide-resistant acetohydroxy acid synthase large subunit proteins comprising a p182l and uses thereof |
| 03/09/2006 | CA2576798A1 Localization and characterization of flavivirus envelope glycoprotein cross-reactive epitopes and methods for their use |
| 03/09/2006 | CA2575481A1 Disarmed agrobacterium strains, ri-plasmids, and methods of transformation based thereon |
| 03/08/2006 | EP1632580A2 Method for quantifying initial concentration of nucleic acids from real-time amplification data |
| 03/08/2006 | EP1632576A2 Novel plant expression constructs |
| 03/08/2006 | EP1632575A1 Human carboxypeptidases and polynucleotides encoding the same |
| 03/08/2006 | EP1632574A1 Fibroblast growth factor homologs |
| 03/08/2006 | EP1632573A2 Modulation of sodium channels in dorsal root ganglia |
| 03/08/2006 | EP1632572A1 Method for separating and purifying nucleic acid |
| 03/08/2006 | EP1632571A1 Human artificial chromosome containing human antibody Lambda light chain and non-human animal containing the human artificial chromosome capable of genetic transmission |
| 03/08/2006 | EP1632569A1 Strain belonging to the genus streptomyces and being capable of producing nemadictin and process for producing nemadictin using the strain |
| 03/08/2006 | EP1632566A2 Cyclomaltodextrin glucanotransferase variants |
| 03/08/2006 | EP1632565A1 Modulation of alkaloid biosynthesis in plants and plants having altered alkaloid biosynthesis |
| 03/08/2006 | EP1632502A1 Methods of detecting collagen degradation in vivo |
| 03/08/2006 | EP1632500A2 A lymphocyte surface receptor that binds CAML, nucleic acids encoding the same and methods of use thereof |
| 03/08/2006 | EP1632499A2 Gene sequences amplified in tumours and their diagnostic uses |
| 03/08/2006 | EP1632496A1 Reagents and methods for solid phase synthesis and display |
| 03/08/2006 | EP1632470A2 Calcium receptor active molecules |
| 03/08/2006 | EP1632248A1 Anti-interleukin-9 antibody or anti-interleukin-9 receptor antibody for treating bronchial hyper-responsiveness |
| 03/08/2006 | EP1632242A2 Novel method for down-regulation of amyloid |
| 03/08/2006 | EP1631823A2 NOVEL REGULATORY MECHANISMS OF NF-kappaB |
| 03/08/2006 | EP1631688A1 Methods for selecting protein binding moieties |
| 03/08/2006 | EP1631685A2 Nucleic acid processing methods, kits and devices |
| 03/08/2006 | EP1631683A1 Therapeutic and diagnostic means for papillomas and other diseases involving ped/pea-15 |
| 03/08/2006 | EP1631682A1 Differentially regulated hepatocellular carcinoma genes and uses thereof |
| 03/08/2006 | EP1631675A1 Methods and kits for mass production of dsrna |
| 03/08/2006 | EP1631674A2 Peptide ligands of dendritic cells for nucleic acid vector targeting |
| 03/08/2006 | EP1631673A2 Recombinant influenza vectors with a polii promoter and ribozymes |
| 03/08/2006 | EP1631672A1 Circular expression construct for gene therapeutic applications |
| 03/08/2006 | EP1631671A1 A coumermycin/novobiocin-regulated gene expression system |
| 03/08/2006 | EP1631670A2 Conserved hbv and hcv sequences useful for gene silencing |
| 03/08/2006 | EP1631669A2 Cochleate compositions directed against expression of proteins |
| 03/08/2006 | EP1631668A1 Purification device for ribonucleic acid in large volumes, and method |
| 03/08/2006 | EP1631666A1 Enzyme with xylanase activity at acidic ph |
| 03/08/2006 | EP1631664A1 Feedback-resistant mevalonate kinases |
| 03/08/2006 | EP1631663A2 High titer recombinant influenza viruses for vaccines and gene therapy |
| 03/08/2006 | EP1631661A2 Transgenic animal having an amyloid precursor protein with a modified beta secretase cleavage site |
| 03/08/2006 | EP1631660A2 Genes encoding carotenoid compounds |
| 03/08/2006 | EP1631659A2 Modulation of the rna interference pathway |
| 03/08/2006 | EP1631584A1 Method for screening inhibitors of the gamma-secretase |
| 03/08/2006 | EP1631583A1 Extracting and purifying enzymes |
| 03/08/2006 | EP1631582A2 Chimeric adenovirus capsid proteins |
| 03/08/2006 | EP1631319A2 In vivo production of a clostridial neurotoxin light chain peptide |
| 03/08/2006 | EP1631314A2 Method of altering the binding specificity of plasma proteins by oxidation-reduction reactions |
| 03/08/2006 | EP1631265A2 Use of various agents for inhibiting fibrous adhesions |
| 03/08/2006 | EP1631238A2 Antibodies specific for cancer associated antigen sm5-1 and uses thereof |